Combatting the Opioid Crisis: The Price Increase of an Opioid Overdose Reversal Drug and the Cost to the U.S. Healthcare System

Loading...
Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
2018-11-18
Report Length
99 pages
Policy Agendas Project Major Code
Additional, Minority, Dissenting Views
Found Using Methodology
Yes
Commission(s)
Idependent Author(s)
Brief Executive Summary
The Homeland Security and Governmental Affairs' Permanent Subcommittee on Investigations conducted several investigations on the opioid epidemic and the Federal Government's response. Specifically, the Subcommittee investigated the cost of naloxone and how a single pharmaceutical company exploited the opioid crisis by increasing the price of the drug. It was discovered that the company increased the price of naloxone by 600 percent, resulting in more than $142 million in charges to taxpayers.
Press Releases and Contextual Information
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views
Citation